EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma

Su, K; Yuan, Q; Hou, H; Ke, CH; Huang, CH; Li, SY; Sun, JW; Yuan, X; Lin, Y; Chen, YQ; Xin, HJ; Liang, XP; Du, ZY; Yuan, ZQ

Liang, XP; Du, ZY; Yuan, ZQ (通讯作者),Guangdong Univ Technol, Sch Biomed & Pharmaceut Sci, Guangzhou 510006, Peoples R China.

JOURNAL OF MOLECULAR MEDICINE-JMM, 2022; 100 (4): 629

Abstract

Hepatocellular carcinoma (HCC) is an aggressive malignancy, and its effective treatment has been hampered by drug resistance. Extracellular vesicle (E......

Full Text Link